CN105713859A - 短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 - Google Patents
短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 Download PDFInfo
- Publication number
- CN105713859A CN105713859A CN201610128905.6A CN201610128905A CN105713859A CN 105713859 A CN105713859 A CN 105713859A CN 201610128905 A CN201610128905 A CN 201610128905A CN 105713859 A CN105713859 A CN 105713859A
- Authority
- CN
- China
- Prior art keywords
- milk
- sample
- standard
- detection
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 57
- 235000013336 milk Nutrition 0.000 title claims abstract description 51
- 239000008267 milk Substances 0.000 title claims abstract description 51
- 210000004080 milk Anatomy 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 40
- 241000186012 Bifidobacterium breve Species 0.000 title claims abstract description 34
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims abstract description 52
- 238000001514 detection method Methods 0.000 claims abstract description 49
- 239000004098 Tetracycline Substances 0.000 claims abstract description 32
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 32
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 32
- 229960002180 tetracycline Drugs 0.000 claims abstract description 30
- 229930101283 tetracycline Natural products 0.000 claims abstract description 30
- 229960003276 erythromycin Drugs 0.000 claims abstract description 26
- 238000012216 screening Methods 0.000 claims abstract description 26
- 230000001580 bacterial effect Effects 0.000 claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 19
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 18
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 18
- 238000004321 preservation Methods 0.000 claims abstract description 15
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 14
- 229930182555 Penicillin Natural products 0.000 claims abstract description 10
- 229940049954 penicillin Drugs 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 230000004913 activation Effects 0.000 claims abstract description 4
- 238000012360 testing method Methods 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 21
- 229960000723 ampicillin Drugs 0.000 claims description 21
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 21
- 239000012224 working solution Substances 0.000 claims description 20
- 238000002835 absorbance Methods 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000012086 standard solution Substances 0.000 claims description 8
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- -1 2.5g Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 5
- 239000007836 KH2PO4 Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 150000002333 glycines Chemical class 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 230000009514 concussion Effects 0.000 claims description 3
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 239000013641 positive control Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 7
- 238000007689 inspection Methods 0.000 abstract description 2
- 238000011177 media preparation Methods 0.000 abstract 2
- 238000011109 contamination Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000013642 negative control Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 150000003952 β-lactams Chemical class 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 230000009604 anaerobic growth Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 2
- 229960002292 piperacillin Drugs 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940040944 tetracyclines Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000734166 Ephebe Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 238000002829 antibacterial sensitivity test Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229960002100 cefepime Drugs 0.000 description 1
- HVFLCNVBZFFHBT-ZKDACBOMSA-N cefepime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2415/00—Assays, e.g. immunoassays or enzyme assays, involving penicillins or cephalosporins
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610128905.6A CN105713859B (zh) | 2016-03-02 | 2016-03-02 | 短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610128905.6A CN105713859B (zh) | 2016-03-02 | 2016-03-02 | 短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105713859A true CN105713859A (zh) | 2016-06-29 |
CN105713859B CN105713859B (zh) | 2021-01-01 |
Family
ID=56157452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610128905.6A Active CN105713859B (zh) | 2016-03-02 | 2016-03-02 | 短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105713859B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107314980A (zh) * | 2017-06-08 | 2017-11-03 | 中国肉类食品综合研究中心 | 一种动物源性食品中多种抗生素残留检测试剂盒及检测方法 |
CN109971669A (zh) * | 2019-02-01 | 2019-07-05 | 温州医科大学 | 假链状双歧杆菌及牛奶中抗生素残留的检测方法及应用 |
CN109971670A (zh) * | 2019-02-01 | 2019-07-05 | 温州医科大学 | 粪肠球菌、其培养基及牛奶中抗生素残留的检测方法及应用 |
CN110257471A (zh) * | 2019-06-06 | 2019-09-20 | 南京农业大学 | 利用生物传感器检测土壤中可提取态四环素类抗生素的试纸条及方法 |
CN110699468A (zh) * | 2019-10-29 | 2020-01-17 | 圣湘生物科技股份有限公司 | 检测人肠道细菌的组合物、试剂盒及方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080199444A1 (en) * | 2006-06-26 | 2008-08-21 | Yunlong Cui | Composition and method for reducing feces toxins and treating digestive disorders |
CN102517230A (zh) * | 2011-12-12 | 2012-06-27 | 温州医学院 | 短双歧杆菌及食品中甲胺磷农药残留的检测方法 |
CN102590196A (zh) * | 2012-01-06 | 2012-07-18 | 温州医学院 | 一种快速筛检动物食品样中抗菌药物残留的检测方法 |
-
2016
- 2016-03-02 CN CN201610128905.6A patent/CN105713859B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080199444A1 (en) * | 2006-06-26 | 2008-08-21 | Yunlong Cui | Composition and method for reducing feces toxins and treating digestive disorders |
CN102517230A (zh) * | 2011-12-12 | 2012-06-27 | 温州医学院 | 短双歧杆菌及食品中甲胺磷农药残留的检测方法 |
CN102590196A (zh) * | 2012-01-06 | 2012-07-18 | 温州医学院 | 一种快速筛检动物食品样中抗菌药物残留的检测方法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107314980A (zh) * | 2017-06-08 | 2017-11-03 | 中国肉类食品综合研究中心 | 一种动物源性食品中多种抗生素残留检测试剂盒及检测方法 |
CN107314980B (zh) * | 2017-06-08 | 2020-02-18 | 中国肉类食品综合研究中心 | 动物源性食品中多种抗生素残留检测试剂盒及检测方法 |
CN109971669A (zh) * | 2019-02-01 | 2019-07-05 | 温州医科大学 | 假链状双歧杆菌及牛奶中抗生素残留的检测方法及应用 |
CN109971670A (zh) * | 2019-02-01 | 2019-07-05 | 温州医科大学 | 粪肠球菌、其培养基及牛奶中抗生素残留的检测方法及应用 |
CN109971670B (zh) * | 2019-02-01 | 2023-01-24 | 温州医科大学 | 粪肠球菌、其培养基及牛奶中抗生素残留的检测方法及应用 |
CN110257471A (zh) * | 2019-06-06 | 2019-09-20 | 南京农业大学 | 利用生物传感器检测土壤中可提取态四环素类抗生素的试纸条及方法 |
CN110257471B (zh) * | 2019-06-06 | 2020-08-18 | 南京农业大学 | 利用生物传感器检测土壤中可提取态四环素类抗生素的试纸条及方法 |
CN110699468A (zh) * | 2019-10-29 | 2020-01-17 | 圣湘生物科技股份有限公司 | 检测人肠道细菌的组合物、试剂盒及方法 |
CN110699468B (zh) * | 2019-10-29 | 2023-05-02 | 圣湘生物科技股份有限公司 | 检测人肠道细菌的组合物、试剂盒及方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105713859B (zh) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105713859A (zh) | 短双歧杆菌及牛奶中多种抗生素残留的检测方法及应用 | |
Mentula et al. | Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs | |
Nebe-von-Caron et al. | Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sorting | |
CN101570782B (zh) | 乳制品中8种致病菌检测试剂盒及其检测方法 | |
Orrhage et al. | Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil | |
AU609794B2 (en) | A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein | |
CN104450860B (zh) | 一种肺炎支原体培养基 | |
CN101130808B (zh) | 分枝杆菌快速培养药敏及鉴定微量检测法及装置 | |
Ritchie et al. | Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection | |
CN101948902A (zh) | 念珠菌显色培养基、检测试剂盒及检测方法 | |
CN101402989A (zh) | 注射器型微生物培养装置 | |
CN101717813B (zh) | 活性乳酸菌饮料中菌落总数的检测方法 | |
CN109762871A (zh) | 一种将单磺酸四氮唑盐与pms衍生物的混合物用于微生物检测的用途及其检测方法 | |
Gilbert et al. | Serological detection of enterotoxin in foods implicated in staphylococcal food poisoning | |
CA2781516C (en) | Culture medium for specific growth, detection, and enumeration of bifidobacterium breve | |
CN101555517A (zh) | 一种肺炎支原体快速鉴定培养药敏试剂盒及检测方法 | |
Carson et al. | Miniaturized tests for computer‐assisted identification of motile Aeromonas species with an improved probability matrix | |
CN105349614A (zh) | 植物乳杆菌特异性培养基及其应用 | |
CN108548746A (zh) | 一种测定羽毛降解率的方法 | |
Agarwal et al. | Utility of stool CBNAAT in the diagnosis of pediatric pulmonary tuberculosis in India | |
Yamagishi et al. | Effect of a lactobacillus product administration on the anaerobic intestinal flora of aged adults | |
CN109971669A (zh) | 假链状双歧杆菌及牛奶中抗生素残留的检测方法及应用 | |
Rahaman et al. | Isolation, identification and characterization of Clostridium perfringens from lamb dysentery in Dinajpur district of Bangladesh | |
CN109161494B (zh) | 具有调节免疫功能的复合菌剂及其制备方法和应用 | |
Waitkins | Evaluation of rapid methods of identifying group B streptococci. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220829 Address after: Room 11342, No. 260, Jiangshu Road, Xixing Street, Binjiang District, Hangzhou City, Zhejiang Province, 310000 (self-declaration) Patentee after: Hangzhou Laoyi Technology Co.,Ltd. Address before: No. 412, 4th floor, building 4, No. 588 Shuhui Road, Qingyang District, Chengdu, Sichuan 610000 Patentee before: Chengdu Feiyou Trading Co.,Ltd. Effective date of registration: 20220829 Address after: No. 412, 4th floor, building 4, No. 588 Shuhui Road, Qingyang District, Chengdu, Sichuan 610000 Patentee after: Chengdu Feiyou Trading Co.,Ltd. Address before: 325035 Wenzhou University Science Park, box 006, 38 Dongfang South Road, Ouhai Economic Development Zone, Wenzhou City, Zhejiang Province Patentee before: WENZHOU MEDICAL University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240112 Address after: No. 2108, Building 2, No. 186 Huangshanmudian Road, Chaoyang District, Beijing, 100000 Patentee after: Wu Chenghu Address before: Room 11342, No. 260, Jiangshu Road, Xixing Street, Binjiang District, Hangzhou City, Zhejiang Province, 310000 (self-declaration) Patentee before: Hangzhou Laoyi Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |